‘Possible link’ between AstraZeneca vaccine and rare blood clots, EMA concludes

‘Possible link’ between AstraZeneca vaccine and rare blood clots, EMA concludes

The European Medicines Agency has come to the conclusion that the unusual blood clots suffered by numerous people around Europe should be considered as rare side effects of AstraZeneca's Covid-19 vaccine, but that overall the benefits of the jab outweigh the risk.

In Europe questions linger over possible AstraZeneca jab side-effects

In Europe questions linger over possible AstraZeneca jab side-effects

French family files case over woman’s death after AstraZeneca jab

French family files case over woman’s death after AstraZeneca jab

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes

AstraZeneca vaccine ‘safe and effective’ against Covid-19, European Medicines Agency concludes

AstraZeneca benefits outweigh risks, EMA says as EU orders 10 million more Pfizer doses

AstraZeneca benefits outweigh risks, EMA says as EU orders 10 million more Pfizer doses

UPDATE: Which countries in Europe have suspended AstraZeneca vaccinations?

UPDATE: Which countries in Europe have suspended AstraZeneca vaccinations?

‘Deeply unfair’: France and Germany struggle to sell AstraZeneca vaccine safety

‘Deeply unfair’: France and Germany struggle to sell AstraZeneca vaccine safety

Several French hospitals pause AstraZeneca vaccine campaign over temporary side effects

Several French hospitals pause AstraZeneca vaccine campaign over temporary side effects